Status:
UNKNOWN
Driver-guided Ablation of Persistent Atrial Fibrillatiom
Lead Sponsor:
IRCCS Policlinico S. Donato
Conditions:
Persistent Atrial Fibrillation
Eligibility:
All Genders
18-85 years
Brief Summary
This is a prospective, single-center, study. A targeted number of 181patients with persistent AF will be included according to pre-defined criteria. The ablation procedure consists on the identificati...
Detailed Description
This is a prospective, single-center, study enrolling a total of 181patients with persistent AF according to well defined inclusion and exclusion criteria. The ablation procedure consists on the ident...
Eligibility Criteria
Inclusion
- Age (18-85 years), persistent AF according to ESC/EHRA guidelines, first or second ablation procedure, ability to provide informed written consent.
- \-
Exclusion
- Secondary AF, Hyperthyroidism, LVEF\<30%, NYHA functional class IV, uncorrected valvular heart diseases, contraindication to anticoagulation, left atrial thrombus, recent (\<6 months) myocardial infarction, thoracic surgery for congenital, valvular diseases, History of cerebrovascular events, pregnancy, cancer or other significant comorbidities.
- \-
Key Trial Info
Start Date :
September 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT04085731
Start Date
September 21 2019
End Date
December 30 2023
Last Update
October 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Policlinico S. Donato
San Donato Milanese, Milano, Italy, 20097